Kingworld Medicines Group Dividende

Zukünftiges Wachstum Kriterienprüfungen 4/6

Kingworld Medicines Group ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 6.73%, die durch die Erträge gut gedeckt ist.

Wichtige Informationen

6.7%

Dividendenausschüttung

3.2%

Rückkaufsrendite

Gesamte Aktionärsrendite	10.0%
Zukünftige Dividendenrendite	n/a
Wachstum der Dividende	12.8%
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	HK$0.0338
Ausschüttungsquote	58%

Aktuelle Dividendenentwicklung

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

May 31

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

Apr 23

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

May 30

Recent updates

Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Oct 04

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

May 31

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

May 22

Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Apr 29

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

Apr 23

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Mar 22

The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

Nov 30

Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Aug 17

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

May 30

The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

May 11

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Apr 03

Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

Feb 07

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Oct 07

Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Jul 05

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

Apr 27

We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Aug 17

Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Apr 24

Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Mar 29

Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Mar 08

Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

Feb 15

Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

Jan 25

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: 1110Die Dividendenzahlungen des Unternehmens waren in den vergangenen 10 Jahren volatil.

Wachsende Dividende: 1110Die Dividendenzahlungen des Unternehmens sind in den letzten 10 Jahren gestiegen.

Dividendenrendite im Vergleich zum Markt

Kingworld Medicines Group Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von 1110 im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (1110)	6.7%
Untere 25 % des Marktes (HK)	3.1%
Markt Top 25 % (HK)	7.8%
Branchendurchschnitt (Healthcare)	4.0%
Analystenprognose (1110) (bis zu 3 Jahre)	n/a

Bemerkenswerte Dividende: 1110Die Dividende des Unternehmens (6.73%) ist höher als die der untersten 25% der Dividendenzahler auf dem Hong Kong Markt (3.15%).

Hohe Dividende: 1110Die Dividende des Unternehmens (6.73%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt Hong Kong (7.83%) niedrig.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Mit einer angemessenen Ausschüttungsquote (58.2%) sind die Dividendenzahlungen von 1110 durch die Gewinne gedeckt.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Mit einer relativ niedrigen Ausschüttungsquote (41.2%) sind die Dividendenzahlungen von 1110 durch den Cashflow gut gedeckt.

Kingworld Medicines Group Dividende

Zukünftiges Wachstum Kriterienprüfungen 4/6

Wichtige Informationen

Aktuelle Dividendenentwicklung

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

Kingworld Medicines Group Limited Approves Final Dividend for the Year Ended 31 December 2023

Upcoming dividend of HK$0.034 per share

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

Kingworld Medicines Group Limited Approves Final Dividend for the Year Ended 31 December 2022

Recent updates

Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

First half 2024 earnings released: EPS: CN¥0.052 (vs CN¥0.064 in 1H 2023)

Kingworld Medicines Group Limited Appoints Chu Xiaoping as Non-Executive Director and Member of the Nomination, Remuneration and Audit Committee, Effective 1 September 2024

Kingworld Medicines Group Limited Appoints Chu Xiaoping as Non-Executive Director and Member of the Nomination, Remuneration and Audit Committee, Effective 1 September 2024

New minor risk - Earnings quality

Kingworld Medicines Group Limited to Report First Half, 2024 Results on Aug 28, 2024

Now 23% undervalued

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

Kingworld Medicines Group Limited Approves Final Dividend for the Year Ended 31 December 2023

Now 22% undervalued

Upcoming dividend of HK$0.034 per share

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Full year 2023 earnings released: EPS: CN¥0.064 (vs CN¥0.037 in FY 2022)

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

Kingworld Medicines Group Limited, Annual General Meeting, May 29, 2024

Full year 2023 earnings released: EPS: CN¥0.064 (vs CN¥0.037 in FY 2022)

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Kingworld Medicines Group Limited to Report Fiscal Year 2023 Final Results on Mar 26, 2024

Now 29% overvalued

The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

New minor risk - Share price stability

First half 2023 earnings released: EPS: CN¥0.064 (vs CN¥0.04 in 1H 2022)

Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Kingworld Medicines Group Limited to Report First Half, 2023 Results on Aug 28, 2023

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

Kingworld Medicines Group Limited Approves Final Dividend for the Year Ended 31 December 2022

Upcoming dividend of HK$0.025 per share at 3.0% yield

The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Full year 2022 earnings released: EPS: CN¥0.037 (vs CN¥0.05 in FY 2021)

Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

Investor sentiment improved over the past week

Insufficient new directors

Now 22% undervalued after recent price drop

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Now 24% undervalued

First half 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.032 in 1H 2021)

Kingworld Medicines Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

Co-Founder recently bought HK$297k worth of stock

Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Kingworld Medicines Group Limited Announces Final Cash Dividend for the Financial Year Ended 31 December 2021, Payable on 30 June 2022

Upcoming dividend of HK$0.024 per share

Full year 2021 earnings released: EPS: CN¥0.05 (vs CN¥0.019 in FY 2020)

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

Less than half of directors are independent

Co-Founder recently bought HK$280k worth of stock

Kingworld Medicines Group Limited Announces Final Dividend for the Year Ended 31 December 2021, Payable on 30 June 2022

Full year 2021 earnings released: EPS: CN¥0.05 (vs CN¥0.019 in FY 2020)

Kingworld Medicines Group Limited, Annual General Meeting, May 27, 2022

Kingworld Medicines Group Limited, Annual General Meeting, May 27, 2022

First half 2021 earnings released: EPS CN¥0.032 (vs CN¥0.016 in 1H 2020)

We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group Limited Declares Final Dividend for the Year Ended December 31, 2020

Full year 2020 earnings released: EPS CN¥0.019 (vs CN¥0.07 in FY 2019)

Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Full year 2020 earnings released: EPS CN¥0.019 (vs CN¥0.07 in FY 2019)

Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group Limited Provides Preliminary Unaudited Consolidated Earnings Guidance for the Year Ended December 31, 2020

Kingworld Medicines Group Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

New 90-day low: HK$0.67

Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

New 90-day low: HK$0.73

Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?

We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt

What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation

Kingworld Medicines Group Limited Enters Distribution Agreement with Shenzhen Ausa Pharmaceutical Co., Ltd